Differences in mRNA-1273 (Moderna) and BNT162b2 (Pfizer-BioNTech) SARS-CoV-2 vaccine immunogenicity among patients undergoing dialysis

BACKGROUND: Differences in immunogenicity between mRNA SARS-CoV-2 vaccines have not been well characterized in patients undergoing dialysis. We compared the serologic response in patients undergoing maintenance hemodialysis after vaccination against SARS-CoV-2 with BNT162b2 (Pfizer-BioNTech) and mRN...

Descripción completa

Detalles Bibliográficos
Autores principales: Yau, Kevin, Chan, Christopher T., Abe, Kento T., Jiang, Yidi, Atiquzzaman, Mohammad, Mullin, Sarah I., Shadowitz, Ellen, Liu, Lisa, Kostadinovic, Ema, Sukovic, Tatjana, Gonzalez, Anny, McGrath-Chong, Margaret E., Oliver, Matthew J., Perl, Jeffrey, Leis, Jerome A., Bolotin, Shelly, Tran, Vanessa, Levin, Adeera, Blake, Peter G., Colwill, Karen, Gingras, Anne-Claude, Hladunewich, Michelle A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: CMA Impact Inc. 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9053976/
https://www.ncbi.nlm.nih.gov/pubmed/35115375
http://dx.doi.org/10.1503/cmaj.211881

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9053976/
https://www.ncbi.nlm.nih.gov/pubmed/35115375
http://dx.doi.org/10.1503/cmaj.211881

Ejemplares similares